| Name | Title | Contact Details |
|---|
Norterre is a revolutionary multi-generational wellness and residential living neighborhood located in the heart of Liberty, Missouri. This master-planned community is the first of its kind in the country, consisting of a significant residential component for all stages of life, including young families, active adults and seniors. Steve Shields, an internationally-known change-agent and innovator of the Senior Living Household Model, is the mastermind behind this revolutionary concept and serves as CEO and managing partner of Norterre. Norterre partners include Liberty Hospital and Healthy Living Centers of America. Norterre will be built on a 17-acre piece of land adjacent to Liberty Hospital, with large greenspaces for cross-generational and cultural activities. A 50,000-square-foot healthy living center will be the neighborhood’s “town square” where young adults, parents and grandparents from all over the Northland can come together to work out, take yoga classes, socialize, build strength, receive physical therapy, learn about wellness, and reach personal milestones in a supportive environment unlike any other. Individuals from near and far can become members to improve physical, mental and spiritual well-being, and doctors can also write prescriptions for patients to take part in physical therapy or specialized programs. Many refer to this concept as a game-changer, as it will unite people of all ages in a way never been done before.
Oxyheal Health Group is a National City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
Optimal Radiology is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Iberia Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Iberia Medical Center is based in New Iberia, LA. You can find more information on Iberia Medical Center at www.iberiamedicalcenter.com